Table 4.
Clinical Outcomes of Patients with COVID-19 According to Liver Test Results
| Outcome | Liver tests (aminotransferase) | Total | p-value | |
|---|---|---|---|---|
| Normal | Abnormal | |||
| No. of patients | 512 (58.6) | 362 (41.4) | 874 | |
| Complications | ||||
| Acute respiratory distress syndrome | 22 (4.3) | 75 (20.7) | 97 (11.1) | <0.001 |
| Acute kidney injury | 10 (2.0) | 34 (9.4) | 44 (5.0) | <0.001 |
| Septic shock | 17 (3.3) | 58 (16.0) | 75 (8.6) | <0.001 |
| Continuous renal replacement therapy | 1 (0.2) | 18 (5.0) | 19 (2.2) | <0.001 |
| Oxygen support | ||||
| Nasal cannula | 80 (15.6) | 83 (22.9) | 163 (18.6) | 0.006 |
| High-flow nasal cannula | 11 (2.1) | 26 (7.2) | 37 (4.2) | <0.001 |
| Invasive mechanical ventilation | 7 (1.4) | 56 (15.5) | 63 (7.2) | <0.001 |
| Extracorporeal membrane oxygenation | 0 | 18 (5.0) | 18 (2.1) | <0.001 |
| Prognosis | ||||
| Release from quarantine | 437 (85.4) | 273 (75.4) | 710 (81.2) | <0.001 |
| Hospitalization | 30 (5.9) | 28 (7.7) | 58 (6.6) | 0.273 |
| Transfer to life treatment centers | 30 (5.6) | 16 (4.7) | 46 (5.3) | 0.348 |
| Death | 15 (2.9) | 47 (13.0) | 62 (7.1) | <0.001 |
| Time to release from quarantine, day | 22 (17–30) | 26 (19–33) | 24 (18–31) | 0.001 |
Data are presented as the number (%) or median (interquartile range).
COVID-19, coronavirus disease 2019.